skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
33.50c) drops 1.5% weakening below moving average price
Material Type:
Newsletter Article
Add to My Research

33.50c) drops 1.5% weakening below moving average price

Company Data Report, 2024

Copyright News Bites Pty Ltd Apr 23, 2024

Digital Resources/Online E-Resources

2
35.0c) sinks 4.1% weakening below moving average price
Material Type:
Newsletter Article
Add to My Research

35.0c) sinks 4.1% weakening below moving average price

Company Data Report, 2024

Copyright News Bites Pty Ltd Apr 15, 2024

Digital Resources/Online E-Resources

3
37.50c) climbs 2.7%, 5 days' volume in a day
Material Type:
Newsletter Article
Add to My Research

37.50c) climbs 2.7%, 5 days' volume in a day

Company Data Report, 2024

Copyright News Bites Pty Ltd Apr 30, 2024

Digital Resources/Online E-Resources

4
38.0c) drops 1.3% weakening below moving average price
Material Type:
Newsletter Article
Add to My Research

38.0c) drops 1.3% weakening below moving average price

Company Data Report, 2024

Copyright News Bites Pty Ltd Apr 9, 2024

Digital Resources/Online E-Resources

5
43.50c) falls 4.4% from 14-day high
Material Type:
Newsletter Article
Add to My Research

43.50c) falls 4.4% from 14-day high

Company Data Report, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

6
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Material Type:
Newsletter Article
Add to My Research

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024

NASDAQ OMX's News Release Distribution Channel, 2024

GlobeNewswire, Inc.

Digital Resources/Online E-Resources

7
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Material Type:
Newsletter Article
Add to My Research

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. May 8, 2024

Digital Resources/Online E-Resources

8
Acadia Pharmaceuticals Presents New DAYBUE (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Material Type:
Newspaper Article
Add to My Research

Acadia Pharmaceuticals Presents New DAYBUE (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting

Business Wire, 2024-04-17

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

9
Acadia Pharmaceuticals Presents New DAYBUE[TM] Annual Meeting
Material Type:
Newspaper Article
Add to My Research

Acadia Pharmaceuticals Presents New DAYBUE[TM] Annual Meeting

Business Wire, 2024-04-17

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

10
Accutar Biotechnology Inc issued patent titled "Heteroaryl Compounds as Egfr Inhibitors and Their Uses"
Material Type:
Newsletter Article
Add to My Research

Accutar Biotechnology Inc issued patent titled "Heteroaryl Compounds as Egfr Inhibitors and Their Uses"

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd Feb 29, 2024

Digital Resources/Online E-Resources

11
Accutar Biotechnology Inc issued patent titled "Heterocyclic Compounds as E3 Ligase Inhibitors"
Material Type:
Newsletter Article
Add to My Research

Accutar Biotechnology Inc issued patent titled "Heterocyclic Compounds as E3 Ligase Inhibitors"

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 9, 2024

Digital Resources/Online E-Resources

12
Adcentrx Therapeutics to Present Preclinical Data for Nectin-4 ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
Material Type:
Newsletter Article
Add to My Research

Adcentrx Therapeutics to Present Preclinical Data for Nectin-4 ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

PR Newswire, 2024

Copyright PR Newswire Association LLC Apr 1, 2024

Digital Resources/Online E-Resources

13
Adicet Bio (ACET: $1.34) in 5th consecutive fall; -39c [22.5%]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.34) in 5th consecutive fall; -39c [22.5%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 15, 2024

Digital Resources/Online E-Resources

14
Adicet Bio (ACET: $1.40) up 5.3% on analyst upgrade; +7c [5.3%] Vol Index 1.7 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.40) up 5.3% on analyst upgrade; +7c [5.3%] Vol Index 1.7 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 16, 2024

Digital Resources/Online E-Resources

15
Adicet Bio (ACET: $1.43) falls in 4 out of last 5 days, 5-day fall of 21%; -9c [5.9%] Vol Index 2.6 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.43) falls in 4 out of last 5 days, 5-day fall of 21%; -9c [5.9%] Vol Index 2.6 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 3, 2024

Digital Resources/Online E-Resources

16
Adicet Bio (ACET: $1.44) in 4th consecutive fall; -29c [16.8%]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.44) in 4th consecutive fall; -29c [16.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 14, 2024

Digital Resources/Online E-Resources

17
Adicet Bio (ACET: $1.46) gains 3.5%, 3 days' volume in a day; +5c [3.5%] Vol Index 2.7 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.46) gains 3.5%, 3 days' volume in a day; +5c [3.5%] Vol Index 2.7 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

18
Adicet Bio (ACET: $1.47) plunges 9.8%; -16c [9.8%]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.47) plunges 9.8%; -16c [9.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 11, 2024

Digital Resources/Online E-Resources

19
Adicet Bio (ACET: $1.50) price 25% below VWAP; -9c [5.7%]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.50) price 25% below VWAP; -9c [5.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 1, 2024

Digital Resources/Online E-Resources

20
Adicet Bio (ACET: $1.57) rises 8.3% from 14-day low; +8c [5.4%] Vol Index 2.0 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Adicet Bio (ACET: $1.57) rises 8.3% from 14-day low; +8c [5.4%] Vol Index 2.0 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 2, 2024

Digital Resources/Online E-Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait